Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Response Surface Model Between Remimazolam and Sevoflurane
NCT07620782Recruiting
- Sponsor
- Pusan National University Hospital
- Start
- May 2026
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Randomised, open-label trial of remimazolam and sevoflurane, sponsored by Pusan National University Hospital. Primary endpoints: Interaction coefficient (α) between remimazolam and sevoflurane derived from the Minto response surface model and Interaction parameter between remimazolam and sevoflurane derived from the Greco response surface model. Started May 2026; status: recruiting.
02
Drugs
remimazolamsevoflurane
Beyond the preview
Go deeper on NCT07620782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07620782.